Success Metrics

Clinical Success Rate
96.4%

Based on 27 completed trials

Completion Rate
96%(27/28)
Active Trials
3(8%)
Results Posted
15%(4 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_2
19
50%
Ph early_phase_1
1
3%
Ph phase_3
14
37%
Ph phase_1
2
5%
Ph not_applicable
2
5%

Phase Distribution

3

Early Stage

19

Mid Stage

14

Late Stage

Phase Distribution38 total trials
Early Phase 1First-in-human
1(2.6%)
Phase 1Safety & dosage
2(5.3%)
Phase 2Efficacy & side effects
19(50.0%)
Phase 3Large-scale testing
14(36.8%)
N/ANon-phased studies
2(5.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.1%

27 of 31 finished

Non-Completion Rate

12.9%

4 ended early

Currently Active

3

trials recruiting

Total Trials

38

all time

Status Distribution
Active(3)
Completed(27)
Terminated(4)
Other(4)

Detailed Status

Completed27
unknown4
Withdrawn3
Active, not recruiting2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
38
Active
3
Success Rate
96.4%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (2.6%)
Phase 12 (5.3%)
Phase 219 (50.0%)
Phase 314 (36.8%)
N/A2 (5.3%)

Trials by Status

completed2771%
recruiting13%
unknown411%
active_not_recruiting25%
withdrawn38%
terminated13%

Recent Activity

3 active trials
Showing 5 of 38
recruitingphase_3

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

NCT05675410
active_not_recruitingphase_3

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

NCT00002462
completedphase_3

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma

NCT00049595
active_not_recruitingphase_3

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

NCT00379041
completedphase_2

Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma

NCT00003375
View all 38 trials

Clinical Trials (38)

Showing 20 of 38 trialsScroll for more
NCT05675410Phase 3

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Recruiting
NCT00002462Phase 3

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

Active Not Recruiting
NCT00049595Phase 3

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma

Completed
NCT00379041Phase 3

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

Active Not Recruiting
NCT00003375Phase 2

Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma

Completed
NCT00678327Phase 3

Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma

Completed
NCT00574496Phase 2

Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma

Completed
NCT01775475Phase 2

Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma

Completed
NCT00822120Phase 2

S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

Completed
NCT00079092Phase 2

Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma

Completed
NCT01132807Phase 2

Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Completed
NCT00433459Phase 3

Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

Completed
NCT00416832Phase 2

Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma

Completed
NCT00002569Phase 3

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

Completed
NCT00074191Phase 2

Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma

Completed
NCT00079105Phase 2

A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years

Completed
NCT00002806Phase 2

Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma

Completed
NCT00005796Phase 1

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Completed
NCT00666484Phase 2

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

Completed
NCT00004010Phase 2

Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease

Completed

Drug Details

Intervention Type
DRUG
Total Trials
38